These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 3816590

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A, Yogev A, Confino-Cohen R.
    Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Results of hyposensitization with bee and wasp venom].
    Adolph J, Dehnert I, Fischer JF, Wenz W.
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adverse reactions to venom immunotherapy.
    Ramirez DA, Londono S, Evans R.
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G, Sin BA, Misirligil Z.
    J Investig Allergol Clin Immunol; 2006 Dec; 16(4):232-8. PubMed ID: 16889280
    [Abstract] [Full Text] [Related]

  • 11. [Bee and wasp venom allergy. Clinical aspects, prevention and therapy].
    Ring J, Lonsdorf G, Schury W, Burg G.
    MMW Munch Med Wochenschr; 1982 Jun 18; 124(24):587-90. PubMed ID: 6810134
    [No Abstract] [Full Text] [Related]

  • 12. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC, Pedro E, Spínola Santos A, Branco Ferreira M, Palma Carlos ML, Palma Carlos AG.
    Eur Ann Allergy Clin Immunol; 2005 Sep 18; 37(7):273-8. PubMed ID: 16285233
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
    Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P.
    J Investig Allergol Clin Immunol; 2006 Sep 18; 16(2):79-85. PubMed ID: 16689180
    [Abstract] [Full Text] [Related]

  • 17. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
    Gorska L, Chelminska M, Kuziemski K, Skrzypski M, Niedoszytko M, Damps-Konstanska I, Szymanowska A, Siemińska A, Wajda B, Drozdowska A, Jutel M, Jassem E.
    Int Arch Allergy Immunol; 2008 Sep 18; 147(3):241-5. PubMed ID: 18594155
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bee and wasp venom allergy in Turkey.
    Kalyoncu AF, Demir AU, Ozcan U, Ozkuyumcu C, Sahin AA, Bariş YI.
    Ann Allergy Asthma Immunol; 1997 Apr 18; 78(4):408-12. PubMed ID: 9109709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.